Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
783.50    14.00 (1.82%)
Bid:
779.00
Ask:
781.50
Spread: 2.50 (0.321%)
Market Cap: £902.39m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Director/PDMR Shareholding

10 Feb 2021 17:00

RNS Number : 6814O
Kainos Group plc
10 February 2021
Ā 

10 February 2021

Kainos Group plc

("Kainos" or the "Company")Ā 

Director/PDMR Shareholdings

Ā 

The Company was notified on 9 February 2021, that Paul Gannon, Director, sold 200,000 ordinary shares in the Company at an aggregated price of £13.35 per ordinary share.

The Company was further notified on 10 February 2021, that Mr Gannon transferred 50,000 ordinary shares in the Company to a Family Partnership for nil consideration.

Following this notification, Paul Gannon and his Connected Persons have a reportable shareholding of 7,729,008 ordinary shares in the issued share capital of the Company constituting 6.3% of the issued share capital of the Company.

Director / PDMR shareholdings

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Ā 

Ā 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Paul Gannon

2.

Reason for the notification

a.

Position/status

Director

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.(i)

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

Ā 

Ā 

KNOS

b.

Nature of the transaction

Sale of Shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Ā£13.35

200,000

d.

Aggregated information

Ā· Aggregated volume

Ā· Price

Ā 

N/A

e.

Date of the transaction

09- February

f.

Place of the transaction

LSE - Regulated Market - XLON

4.(ii)

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

Ā 

Ā 

KNOS

b.

Nature of the transaction

Transfer of shares into a Family Partnership

c.

Price(s) and volume(s)

Price(s)

Volume(s)

NIL

50,000

d.

Aggregated information

Ā· Aggregated volume

Ā· Price

Ā 

N/A

e.

Date of the transaction

10-February-2020

f.

Place of the transaction

LSE - Regulated Market - XLON

Ā 

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47Ā 

Ā 

Ends

Ā 

For further information, please contact:

Ā 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Ā 

Investec Bank plc +44Ā 20 7597 5970

Patrick Robb / Ben Griffiths

Ā 

Canaccord Genuity +44 20 7523 4606

Simon Bridges/ Emma Gabriel

Ā 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning

Ā 

About Kainos

KainosĀ Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.Ā 

Ā 

The Group's Digital Services include full lifecycle development and support ofĀ customisedĀ Digital Services for government and commercial customers.Ā KainosĀ is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.Ā 

Ā 

The Group's Digital Platforms compriseĀ specialisedĀ digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for theĀ digitisationĀ of patient notes in the Acute sector of the NHS.

Ā 

Kainos has over 1,700 people across 15 offices in Europe and North America.

KainosĀ is listed on the London Stock Exchange (LSE: KNOS). For further information, please visitĀ www.kainos.com.

Ā 

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
DSHDKKBPABKDOBD
Date   Source Headline
8th Mar 20161:38 pmRNSDirector/PDMR Shareholding
1st Mar 201610:00 amRNSDirector/PDMR Shareholding
11th Feb 20166:09 pmRNSDirector/PDMR Shareholding
1st Feb 20167:00 amRNSInvestment in Cirdan Imaging Limited
27th Jan 201611:32 amRNSDirector/PDMR Shareholding
29th Dec 20152:59 pmRNSDirector/PDMR Shareholding
23rd Dec 201511:06 amRNSTransfer of Shares
21st Dec 201510:00 amRNSDisposal of investment in SpeechStorm Limited
18th Dec 20152:42 pmRNSDirector/PDMR Shareholding
17th Dec 20154:46 pmRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim Results
30th Sep 201512:27 pmRNSDirector/PDMR Shareholding
15th Sep 20155:54 pmRNSDirector/PDMR Shareholding
9th Sep 20155:27 pmRNSDirector/PDMR Shareholding
7th Sep 20159:00 amRNSNotice of Results
25th Aug 20158:00 amRNSNew Mobile-Enabled healthcare platform
24th Aug 20155:31 pmRNSDirector/PDMR Shareholding
6th Aug 20157:00 amRNSHolding(s) in Company
16th Jul 20159:05 amRNSDirector/PDMR Shareholding
10th Jul 20157:00 amRNSAdmission to trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.